Q2 2023 Holdings
Filed 2023-08-11 | 12 holdings | $75.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $25.7M | 7,050,000 | 33.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $12.5M | 630,380 | 16.6% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $9.7M | 9,248,250 | 12.8% |
| Springworks Therapeutics Inc | COM | 85205L107 | $5.2M | 197,700 | 6.8% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $5.0M | 6,000,000 | 6.6% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $3.7M | 346,190 | 4.9% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $3.5M | 142,500 | 4.7% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $3.1M | 1,910,600 | 4.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.9M | 166,200 | 3.8% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $2.4M | 67,400 | 3.2% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $2.0M | 363,800 | 2.6% |
| Neximmune Inc | COM | 65344D109 | $37.6K | 133,442 | 0.0% |